Clinical trial
ICATA Asthma Mechanistic Study
NCT00377390 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00377390 |
|---|---|
| Title | ICATA Asthma Mechanistic Study |
| Official title | Inner-City Anti-IgE Therapy for Asthma Mechanistic Study |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Asthma |
| Intervention type | Biological |
| Interventions | Omalizumab |
| Enrollment | 224 |
| Start date | Oct 1, 2006 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Sep 18, 2006 |
| Last update posted | Feb 7, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: